LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)

Filter results: >>>>
Cell Small Molecule GR_AOC
Hs 578T PF477736 0.7780
Hs 578T PF562271 0.3962
Hs 578T PHA-665752 0.1158
Hs 578T PHA-793887 0.8310
Hs 578T PI103 0.7197
Hs 578T PIK-93 0.1800
Hs 578T PLX-4720 -0.0435
Hs 578T QL-X-138 0.4643
Hs 578T QL-XII-47 0.4994
Hs 578T R406 0.2744
Hs 578T Radicicol 0.4846
Hs 578T Sirolimus 0.3724
Hs 578T Ruxolitinib 0.0710
Hs 578T Saracatinib 0.2511
Hs 578T SB590885 -0.0425
Hs 578T Selumetinib 0.5457
Hs 578T Sigma A6730 0.1411
Hs 578T Sorafenib -0.1124
Hs 578T SU11274 0.1522
Hs 578T Fedratinib 0.3610
Hs 578T TGX221 0.1622
Hs 578T Torin1 0.8745
Hs 578T Torin2 0.9986
Hs 578T Tozasertib 0.9070
Hs 578T Trametinib 0.8049